News
Videos
Conferences
Events
Resources
Subscribe

|Videos|January 20, 2016

A Promising Future for Pancreatic Cancer

Episodes in this series

EP. 1 Treatment Options and Challenges for Patients With Pancreatic Cancer

EP. 1 Treatment Options and Challenges for Patients With Pancreatic Cancer

EP. 2 A Promising Future for Pancreatic Cancer

EP. 2 A Promising Future for Pancreatic Cancer

EP. 3 Pancreatic Cancer: David's Story to Remission

EP. 3 Pancreatic Cancer: David's Story to Remission

EP. 4 Pancreatic Cancer: Donald's Story

EP. 4 Pancreatic Cancer: Donald's Story

EP. 5 Locating Support Resources for Patients

EP. 5 Locating Support Resources for Patients

EP. 6 Treatment Considerations for Patients Researching Their Options

EP. 6 Treatment Considerations for Patients Researching Their Options

EP. 7 Moving Forward With Pancreatic Cancer

EP. 7 Moving Forward With Pancreatic Cancer

EP. 8 Receiving a Second Opinion

EP. 8 Receiving a Second Opinion

EP. 9 Maintenance Therapy: What to Expect

EP. 9 Maintenance Therapy: What to Expect

Newsletter

Stay up to date on cancer updates, research and education

Related Content

"FDA" text.

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

December 15th 2025

Image of Debbie.

Accepting That You Are Changed by Cancer

ByDebbie Legault

December 15th 2025

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower: © stock.adobe.com.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

December 12th 2025

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

ByJason Broderick

December 12th 2025

image of woman.

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

December 12th 2025

Trending on CURE

Acupuncture Improves Cognitive Function in Breast Cancer Survivors

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

Light the Night and Survivorship: The Importance of Remembrance

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

© 2025 MJH Life Sciences^®

All rights reserved.